Picture of IDEAYA Biosciences logo

IDYA — IDEAYA Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Ideaya Biosciences Inc Reports Results For The Quarter Ended December 31: Earnings Summary

* IDEAYA Biosciences Inc  IDYA.OQ  reported a quarterly
adjusted
loss of $1.49​​ per share for the quarter ended December 31,
lower than the same quarter last year, when the company reported
EPS of -52 cents.  The mean expectation of thirteen analysts for
the quarter was for a loss of 64 cents per share. Wall Street
expected results to range from -73 cents to -41 cents per share.
    * Revenue rose 78.4% to $7.00 million from a year ago;
analysts
expected $4.67 million. 
    * IDEAYA Biosciences Inc's reported EPS for the quarter was
a loss
of $1.49​.
    * The company reported a quarterly loss of $130.31 million.
    * IDEAYA Biosciences Inc shares had fallen by 18.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for IDEAYA
Biosciences Inc is $52.00 
This summary was machine generated from LSEG data February 18 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.64          -1.49          Missed
 Sep. 30 2024      -0.63          -0.60          Beat
 Jun. 30 2024      -0.54          -0.68          Missed
 Mar. 31 2024      -0.51          -0.53          Missed

Recent news on IDEAYA Biosciences

See all news